Therapygenetics: how is effectiveness of psychotherapy related to genotype?

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Effectiveness of psychotherapy and of clinico-psychological interventions depends on different factors: skills and characteristics of a specialist; diagnosis and extent of severity of symptoms; social and personal peculiarities of patient/client; parameters of psychotherapeutic contact. Therapygenetics is a trend of applied research at the interface of molecular genetics and psychotherapy, which considers molecular-genetic predictors of success/failure of psychotherapeutic interventions.

The aim of the article is analysis and summarization of the current research works in the field of therapygenetics, substantiation of their theoretical and practical significance for psychiatry, psychotherapy and clinical psychology, discussion of the existing limitations and requirements to the design of the respective applied research works. By the moment, contra-dictory, but at the same promising positions in therapygenetics can be outlined. In the given article the results of therapygenetic research performed mostly in accordance with methods of identification of candidate genes, are systematized. Gene-environment correlations in psycho-therapy of anxiety and depressive disorders in children and adults are described. Scarce studies of genetic predictors of effectiveness of psychotherapy in posttraumatic stress-related disorders are summarized. While planning a therapygenetic study, the following methodological, methodical and organizational aspects should be taken into consideration: sufficient representativeness of an experimental sample both from the point of view of socio-demographic characteristics and from the point of view of the diagnosis and used therapy; existence of the control group; use of assessment scales and semi-structured diagnostic interviews for assessment of functioning of respondents; universalization of protocols of assessment of the results of application of methods of psychotherapy; use of polygenomic search for associations; observance of confidentiality and provision of respondents with minimally effective ways of rendering psychological assistance.

Full Text

Restricted Access

About the authors

Anna G. Faustova

Ryazan State Medical University

Author for correspondence.
Email: anne.faustova@gmail.com
ORCID iD: 0000-0001-8264-3592
SPIN-code: 5869-7409
ResearcherId: AAS-5395-2020

PhD in Psychology, Head of the Department of Clinical Psychology

Russian Federation, 390026, Ryazan, 9, Vysokovol'tnaya str.

Michael Wang

University of Leicester

Email: anne.faustova@gmail.com

Honorary Consultant Clinical Neuropsychologist, Emeritus Professor of Clinical Psychology

United Kingdom

References

  1. Pugovkina OD, Nikitina IV, Holmogorova AB, et al. Academic research of therapy process and efficient: History and main topics. Moskovskiy Psikhoterapevticheskiy Zhurnal. 2009;(1):35-68. (In Russ).
  2. Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: Classification and criteria changes. World Psychiatry. 2013;12(2):92-8. doi: 10.1002/wps.20050
  3. ICD-11 for Mortality and Morbidity Statistics (ICD-11 MMS). Available at: https://icd.who.int/browse11/l-m/en. Accessed: 2020 September 25.
  4. Russell RL, Orlinsky DE. Psychotherapy research in historical perspective. Implications for mental health care policy. Archives of General Psychiatry. 1996;53(8):708-15. doi: 10.1001/archpsyc.1996.01830080060010
  5. Eysenck HJ. The effects of psychotherapy: An evaluation. Journal of Consulting Psychology. 1952;16(5):319-24. doi: 10.1037/h0063633
  6. Wallerstein RS. The psychotherapy research prоjet (PRP) of the Menninger Foundation: An overview. Journal of Consulting and Clinical Psychology. 1989;57(2):195-205.
  7. Ayzenk GDzh. Sorok let spustya: novyy vzglyad na problemy effektivnosti v psikhoterapii. Psikhologicheskiy Zhurnal. 1994;14(4):3-19. (In Russ).
  8. Kholmogorova AB. Two conflicting methodologies in the studies of psychotherapy and its efficiency: looking for a third way A.B. Kholmogorova. Part I. Moskovskiy Psikhoterapevticheskiy Zhurnal. 2009; (4):5-25. (In Russ).
  9. Kholmogorova AB, Garanyan NG, Nikitina IV, et al. Research concerning the process of psychotherapy and its efficacy: current situation. Part 2. Sotsial’naya i Klinicheskaya Psikhiatriya. 2010;20 (1):70-9. (In Russ).
  10. Eley TC, Hudson JL, Creswell C, et al. Therapy-genetics: The 5HTTLPR and response to psychological therapy. Molecular Psychiatry. 2012;17(3): 236-7. doi: 10.1038/mp.2011.132
  11. Karg K, Burmeister M, Shedden K, et al. The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-Analysis Revisited: Evidence of Genetic Moderation. Archives of Gene-ral Psychiatry. 2011;68(5):444-54. doi: 10.1001/archgenpsychiatry.2010.189
  12. Steel Z, Marnane C, Iranpour C, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. International Journal of Epidemiology. 2014;43(2):476-93. doi: 10.1093/ije/dyu038
  13. Neznanov NG, Martynikhin IA, Mosolov SN.
  14. Diagnosis and treatment of Anxiety Disorders in Russia: The Results of a Web-based Survey of
  15. Psychiatrists. Sovremennaya terapiya psikhicheskikh rasstroystv. 2017;(2):2-13. doi: 10.21265/PSYPH.2017.41.6437
  16. Gregory AM, Eley TC. The genetic basis of child and adolescent anxiety. In: Silverman W.K., Field A.P., editors. Anxiety Disorders in Children and Adolescents. Cambridge: Cambridge University Press; 2011. P. 161-78.
  17. Stein MB, Schork NJ, Gelernter J. Gene-by-Environment (Serotonin Transporter and Childhood Maltreatment) Interaction for Anxiety Sensitivity, an Intermediate Phenotype for Anxiety Disorders. Neuropsychopharmacology. 2008;33(2):312-9. doi: 10.1038/sj.npp.1301422
  18. Furmark T, Carlbring P, Hammer S, et al. Effects of Serotonin Transporter and Tryptophan Hydroxylase-2 Gene Variation on the Response to Cognitive-Behavior Therapy in Individuals with Social Anxiety Disorder. Biological Psychiatry. 2010;67:1S-271S.
  19. Lonsdorf TB, Ruck C, Bergstrom J, et al. The COMT val158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder. BMC Psychiatry. 2010;(10):99. doi: 10.1186/1471-244X-10-99
  20. Lester KJ, Hudson J, Tropeano M, et al. Neurotrophic gene polymorphisms and response to psychological therapy. Translational Psychiatry. 2012; 2(5):e108. doi: 10.1038/tp.2012.33
  21. Hedman E, Andersson E, Ljótsson B, et al. Clinical and genetic outcome determinants of Internet and group-based cognitive behavior therapy for social anxiety disorder. Acta Psychiatrica Scandinavica. 2012;126(2):126-36. doi: 10.1111/j.1600-0447.2012.01834.x
  22. Fullana MA, Alonso P, Gratacos M, et al. Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder. European Psychiatry. 2012; 27(5):386-90. doi: 10.1016/j.eurpsy.2011.09.005
  23. Depressiya v Rossiyskoy Federatsii (2017). Available at: https://www.euro.who.int/ru/countries/russian-federation/data-and-statistics/infographic-depression-in-the-russian-federation-2017. Accessed: 2020 September 25. (In Russ).
  24. Depression. Available at: https://www.who.int/news-room/fact-sheets/detail/depression. Accessed: 2020 September 25.
  25. Sullivan PF, Neale MC, Kendler K. Genetic epidemiology of major depression: review and meta-analysis. The American Journal of Psychiatry. 2000; 157(10):1552-62. doi: 10.1176/appi.ajp.157.10.1552
  26. Anttila V, Bulik-Sullivan B, Finucane HK, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018;360(6395):eaap8757. doi: 10.1126/science.aap8757
  27. Lester KJ, Eley TC. Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biology of Mood & Anxiety Disorders. 2013;3(1):4. doi: 10.1186/2045-5380-3-4
  28. Kotte A, McQuaid JR, Kelsoe J. HTR2A: Genotypic Predictor of Depression Psychotherapy Treatment Outcome. San Diego, California: 62nd Annual Sci-entific Convention and Meeting of the Society of Biological Psychiatry; 2007.
  29. Bakker JM, Lieverse R, Menne-Lothmann C. Therapygenetics in mindfulness-based cognitive therapy: do genes have an impact on therapy-induced change in real-life positive affective experiences? Translational Psychiatry. 2014;4(4):e384. doi: 10.1038/tp.2014.23
  30. Andersson E, Crowley JJ, Lindefors N, et al. Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary report. Molecular Psychiatry. 2019;24(4):484-90. doi: 10.1038/s41380-018-0289-9
  31. Rayner C, Coleman JRI., Purves KL. A genome-wide association meta-analysis of prognostic out-comes following cognitive behavioural therapy in individuals with anxiety and depressive disorders. Translational Psychiatry. 2019;9(1):150. doi: 10.1038/s41398-019-0481-y
  32. Keesler R, Aguilar-Gaxiola S, Alonso J, et al. Trauma and PTSD in the WHO World Mental Health Surveys. European Journal of Psychotraumatology. 2017;8(suppl 5):1353383. doi: 10.1080/20008198.2017.1353383
  33. Li L, Bao Y, He S, et al. The Association Between Genetic Variants in the Dopaminergic System and Posttraumatic Stress Disorder: A Meta-Analysis.
  34. Medicine. 2016;95(11):e3074. doi: 10.1097/MD.0000000000003074
  35. Castro-Vale I, van Rossum EF, Machado JC, et al. Genetics of glucocorticoid regulation and post-traumatic stress disorder – What do we know?. Neuroscience and Biobehavioral Review. 2016; 63:143-57. doi: 10.1016/j.neubiorev.2016.02.005
  36. Gressier F, Calati R, Balestri M, et al. The 5-HTTLPR polymorphism and post-traumatic
  37. stress disorder: a meta-analysis. Journal of
  38. Traumatic Stress. 2013;26(6):645-53. doi: 10.1002/jts.21855
  39. Bryant RA, Felmingham KL, Falconer EM, et al. Preliminary Evidence of the Short Allele of the Serotonin Transporter Gene Predicting Poor Response to Cognitive Behavior Therapy in Posttraumatic Stress Disorder. Biological Psychiatry. 2010; 67(12):1217-9. doi: 10.1016/j.biopsych.2010.03.016
  40. Wang Z., Harrer J., Tuerk P., et al. 5-HTTLPR Influence PTSD Treatment Outcome. Vancouver, Canada: 64th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry; 2009.
  41. Lau JYF, Eley TC. Changes in genetic and environmental influences on depressive symptoms across adolescence and young adulthood. British Journal of Psychiatry. 2006;189(5):422-7. doi: 10.1192/bjp.bp.105.018721
  42. Eley TC. The future of therapygenetics: where will studies predicting psychological treatment response from genomic markers lead? Depression & Anxiety. 2014;31(8):617-20. doi: 10.1002/da.22292
  43. Fedotov IA, Dorovskaya VA, Nazarov DA. The issue of comorbidity of obsessive-compulsive disorder and schizophrenia. Nauka Molodykh (Eruditio Juvenium). 2016;(2):49-55. (In Russ).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Eco-Vector


Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies